차세대 시퀀싱 서비스 시장 규모, 점유율, 성장 분석 : 유형별, 기술별, 워크플로우별, 최종 용도별, 애플리케이션별, 지역별 - 업계 예측(2026-2033년)

Global Next-Generation Sequencing Services Market size was valued at USD 10.28 Billion in 2024 and is poised to grow from USD 12.58 Billion in 2025 to USD 63.4 Billion by 2033, growing at a CAGR of 22.4% during the forecast period (2026-2033).

The global market for next-generation sequencing (NGS) services is witnessing rapid expansion due to its transformative impact across various fields such as biotechnology, medical diagnostics, and virology. This advanced DNA sequencing technology enables the rapid and efficient sequencing of entire genomes, providing significant advantages over traditional methods like Sanger sequencing. Its scalability and high throughput capabilities make NGS essential in clinical laboratory analysis and disease diagnosis worldwide. The technology also facilitates accelerated drug discovery processes in pharmacogenomics and enhances the identification of biomarkers critical for early detection and individualized therapies. As a result, NGS plays a pivotal role in advancing molecular biology, genetics, and the evolution from conventional diagnosis to a precision medicine approach.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Next-Generation Sequencing Services market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Next-Generation Sequencing Services Market Segments Analysis

Global Next-Generation Sequencing Services Market is segmented by type, technology, workflow, end use, application and region. Based on type, the market is segmented into human genome sequencing, single cell sequencing, microbial genome-based sequencing, gene regulation services, animal & plant sequencing and other sequencing services. Based on technology, the market is segmented into sequencing by synthesis, ion semiconductor sequencing, nanopore sequencing, single-molecule real-time sequencing and other technologies. Based on workflow, the market is segmented into pre-sequencing, sequencing and data analysis. Based on end use, the market is segmented into universities & other research entities, hospitals & clinics, pharma & biotech entities and others. Based on application, the market is segmented into diagnostics, oncology, reproductive health, infectious diseases, rare genetic disorders, others, drug discovery, biomarker discovery, microbial genetics, agriculture, and animal research and other applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing (NGS) Services market is experiencing significant growth fueled by ongoing advancements in clinical diagnostics. Various applications, including forensics, reproductive health, personalized medicine, biomarkers, and diagnostics, highlight the versatility and importance of NGS technology. Its analytical precision, high throughput capabilities, and cost-efficiency have established NGS as the preferred choice in clinical laboratories for diagnosing genetic disorders. This innovation not only facilitates accurate diagnoses but also presents a viable approach to managing rare diseases through genomic sequencing. As such, the demand for NGS services continues to rise, propelling market expansion and technological integration across numerous sectors.

Restraints in the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing Services market faces various challenges related to legal and ethical considerations inherent in DNA sequencing. These complex issues encompass cultural sensitivities, concerns about identifiability, the impact of sharing study results, potential stereotyping, the adequacy of informed consent, risk of stigmatization, matters of inclusion, and the unequal benefits to different groups. Together, these moral dilemmas create significant barriers to market growth, as stakeholders must navigate a landscape filled with scrutiny over the implications and consequences of utilizing sequencing technologies responsibly and equitably. Addressing these concerns is crucial for fostering the future development of the market.

Market Trends of the Global Next-Generation Sequencing Services Market

The Global Next-Generation Sequencing Services market is experiencing a notable trend towards the adoption of third-generation sequencing technologies, which are revolutionizing genomic analysis. These advancements, characterized by single-molecule sequencing approaches, eliminate the need for clonal amplification and polymerase chain reaction (PCR), thereby reducing errors associated with these traditional methods. As a result, platforms utilizing Single-Molecule Real-Time (SMRT) sequencing, FRET sequencing, and Nanopore sequencing are gaining traction due to their ability to deliver longer read lengths and simplify preparatory workflows. This evolution not only enhances the accuracy of sequencing but also broadens applications across medical research, diagnostics, and personalized medicine, driving significant growth in the sector.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Next-Generation Sequencing Services Market Size by Type & CAGR (2026-2033)

• Market Overview
• Human Genome Sequencing
• Single Cell Sequencing
• Microbial Genome-Based Sequencing
• Gene Regulation Services
  • Small RNA Sequencing
  • Chip Sequencing
  • Other Gene Regulation-Based Services
• Animal & Plant Sequencing
• Other Sequencing Services

Global Next-Generation Sequencing Services Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Sequencing By Synthesis
• Ion Semiconductor Sequencing
• Nanopore Sequencing
• Single-Molecule Real-Time Sequencing
• Other Technologies

Global Next-Generation Sequencing Services Market Size by Workflow & CAGR (2026-2033)

• Market Overview
• Pre-Sequencing
• Sequencing
• Data Analysis

Global Next-Generation Sequencing Services Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Universities & Other Research Entities
• Hospitals & Clinics
• Pharma & Biotech Entities
• Others

Global Next-Generation Sequencing Services Market Size by Application & CAGR (2026-2033)

• Market Overview
• Diagnostics
• Oncology
• Reproductive Health
• Infectious Diseases
• Rare Genetic Disorders
• Others
• Drug Discovery
• Biomarker Discovery
• Microbial Genetics, Agriculture, And Animal Research
• Other Applications

Global Next-Generation Sequencing Services Market Size & CAGR (2026-2033)

• North America (Type, Technology, Workflow, End Use, Application)
  • US
  • Canada
• Europe (Type, Technology, Workflow, End Use, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Technology, Workflow, End Use, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Technology, Workflow, End Use, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Technology, Workflow, End Use, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BGI Genomics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eurofins Scientific SE (Luxembourg)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Macrogen, Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pacific Biosciences of California, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Oxford Nanopore Technologies plc (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novogene Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Psomagen, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• 10x Genomics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zymo Research Corp. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CD Genomics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedGenome Labs Pvt Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fulgent Genetics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Personalis, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations